
	July 3, 2008

Now Available:
Watch video podcasts of the 2008 EULAR press conferences

Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment. MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts.

With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.

MSK Video Report:

Floris Lafeber, PhD presents "Joint distraction in the treatment of severe knee osteoarthritis: the first results on clinical efficacy and structual repair" at the 2008 EULAR Congress

News Analysis: Bush Administration Freezes Medicare Fee Cuts
DHHS has temporarily frozen the 10.6% Medicare fee cut that had been set to take effect after July 1...

Bones: Heel Ultrasound Improves Osteoporosis Diagnosis
A heel quantitative ultrasound coupled with an assessment of specific osteoporosis-related risk factors in patients can help doctors predict fracture risk and decide who would need further screening with dual-energy X-ray absorptiometry (DXA)...

Consumer News: Small Protein May Have Big Role In Making More Bone And Less Fat
The protein GILZ may be the key to developing therapies to fight both obesity and osteoporosis...

BioPharm Business: Centocor Requests Approval From FDA of Golimumab for the Treatment of RA, Psoriatic Arthritis, and Ankylosing Spondylitis
Centocor submitted a Biologics License Application to the US FDA requesting the approval of golimumab, a human anti-TNFα monoclonal antibody, as a monthly subcutaneous treatment for adults with active forms of RA, PsA, and AS...

BioPharm Business: Biotie Reports Positive Phase 1a Data for Anti-VAP-1 Monoclonal Antibody BTT-1023; Dosing Regimens to be Established in RA and Psoriasis Patients
Biotie's first-in-human study of BTT-1023 investigated the safety, tolerability, and pharmacokinetic characteristics of single intravenous doses of the antibody in healthy volunteer subjects...